Dr. Stirling Bryan is health economist with extensive experience of engagement with the health policy and decision-making worlds. He began his career in the United Kingdom with appointments at St Thomas' Hospital Medical School and then Brunel University, before moving to the University of Birmingham in 1997.

His research track-record reveals a long-standing goal of informing health policy and practice, demonstrated, in part, through an extensive engagement with the National Institute for Health & Care Excellence (NICE). In 2005 he was awarded a Commonwealth Fund Harkness Fellowship and spent one year at Stanford University, researching health technology coverage decision making in US health care organizations.

Stirling immigrated to Canada in 2008, taking on the roles of professor in UBC's School of Population & Public Health, and director of the Centre for Clinical Epidemiology & Evaluation (C2E2). He provided leadership for C2E2 through until 2018 and remains a senior scientist at the Centre where his research lab is located. Over recent years, he has become a strong advocate for, and practitioner of, patient-oriented research, and now partners with patients in all his research activities.

His current research involves two genomic-focused projects, one exploring the use of pharmacogenomics in the clinical context of major depression and the other investigating the cost-effectiveness of epitope compatibility to guide organ allocation in kidney transplantation.

Stirling is a Fellow of the Canadian Academy of Health Sciences and Chief Scientific Officer for Michael Smith Health Research BC. Currently, he serves as President Elect for the Canadian Association for Health Services & Policy Research and is a co-editor for the Wiley-published journal, Health Economics.